t has co111<: as a surprise that the most common topic in papers so far submitted to the ./"11mal concerns the hi gh rate of mortalit y rro111 asthma in young people. This brought lhL' reali1.ation that I probably know k ss than I ought about the factors thou ght to contribute to asthma mortality, and sent me off LHl a selr-directed learning exen:ise, in true Mc Mas ter tradition. Also in this tradition. I sought hL·lp from ME DLINE and from colleagues that know a lot more than I do. A search or thL· last two )Tars· publications . limited to reviews in English. turned up 33 papcrs. which I will not he· rc•k rencing becau se they arc just as easy for you to retrieve as me 10 list them: ho,-vcver. I will be delighted to send them ll ) any,)ne who wanls them. As to colleagues. I have the good fortune to ha ve Malcolm Scars
close· hy. and he politely and mmlestly sent me a reprint of a paper writtrn in collaboration with a New Zealand colleague. This I round ll) he a superb review and I will give the referen ce as you may nut come across it ( I) . Fro111 these so urces. some thoughts from a 11u11expcrt.
First. many papers n:ler to asthma deaths of epidemic propo rtions. Sears provides the· data to put this statement into perspective. In the I 9o0s deaths from asthma in the five-to :14-ycar age bracket increased in New Zealand. Australia and the United Kingdom from around one· to hctwcrn two ;111d three pL'r I 00.000 persons in thi s age group. !'ailing to one to twn by I Y74: in the period 1977 to 1988 New Zealand L'xpcricnce·d a SL'cond increase that peaked in 1981 when it reac hed 4. I pe r I 00,000. ··a fi gure not matched L"lsewhe•re· in the' world L"ithcr he fore' or since"'. \franwhik. the rate in Canada was between 0.2 and 0.3 in the '60s and '70s and has since crept up to reach 0.5 I in I l)Xh. with !U7 per I 00.(100 in I tJlJ()_ A new study by RS Hogg and colleagues in Vancou ver, publi shed in the ./011mul earlier this ye·ar (21.
cx;1111i11cJ changes i1111wrtali1 y rates and c,llculated their impact on life expectancy. They found a gradual reduction in rates. greater for 111alc-s than J'cmalcs. lru111 ;1 high of 4.5 in ihc L'arly 1950s Ill around 2.0 per I 00.000 in the 1980,: in the age gro up five to 34 years the rat es were approxi111atL·ly I/ 10th of those in Ne·w Zealaml. at (1.20 to 0.45. with no significant trend over the 45 years under study. Hog<> ct al cnncludcd that asthma did not have a significant impact on the overall life expectancy of Canadians. The ·epidemics · of increased mortality rates followed the markL·ting nf' potent beta2-agonists and declines in mortality followed reductions in their use: Scar · and Taylo r provide the evidence in their revi ew. and have been in the forefront of research on which this conclusion may be based . Bearing in mind the recent report of the World Health Organ il'.ati on that poverty is thL· main cause of illness and death in developing countries. the absence of stati stics fro m poorer countries is probably of g reat importance: the: data rev iewed by Sears and Taylor were obtained in six of the G-7 countrie·s and in five others that probably !eel that they :ilso should be in thi s economic grouping. None or them will be within an mdn ol magnitude nf the countries that spend as lillk: as $4 for each of their subjects per year on health care.
Second. several of the re views provide evidence from the United States that show higher mortality in Blacks than in Caucasian.,. ,111d within L"ities such as cw Y l)rk :wd Chicago higher rates in the poorer areas. Aho in those areas. males outnumbered krualc·. , hy thre'L' to one: drnµ abu se was not a factor. Clearly psychosocial .iml ,·rnnomic fact ors that may influence access to care' and dkc1iw tre·atnK'nl an: of great importance. In a stud y of patients dying in Brooklyn. only two ol 14 patients wt're rt•ceivi ng steroids.
Third. a number or studies have tried ll> explain wh y individual patient s died lrom asthma. All considerl'd must of the dea1hs as prcvcruahlc· ,md providt·d evidence that the foll owing fa ctors wnc important: pour perception or asthma severity: i11adc4uatc e·due·ation regarding th e illness and poor compliance with treatment: delay in scd;ing treatment: and signific:llll iatrogc ni c factors re·.,ulting in an inadt'quate and slow treatment response. Where does this leave us, as Canadian respirologists'/ WL· e·,111 fed happy that our mortality rates ,ire not bctleTcd . but we cannot he co111place·n1. Th,· effect or the soeioeconomic facwrs are worrying. especiall y at a time wh en thc. : re is a risk th ;1t hc,ilth scrviL·e·s arc goinµ to get les., acees. ,iblc: we must ensure that they do not interfere with ac cess w optimal management. The importance of patient edncation ,llld particularly of specific self-management instructions and goa ls of treatment was cn1phasi zed in the recent lir.,t supplc·ment to the .loumul ( I lJ()5 :21 Suppl A I: I A-52A). Finally . education for phys icians must be a prinrity: a recrnl revie w o r the result s of practice audits suggested that man y ph ys icians arc unaware of the guidelines fo r optimal managemcnl of sl'vere asthma .
